AstraZeneca PLC (AZNCF)
135.05
-1.10
(-0.81%)
USD |
OTCM |
Sep 29, 16:00
AstraZeneca Market Cap: 209.31B for Sept. 29, 2023
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 29, 2023 | 209.31B |
| September 28, 2023 | 211.02B |
| September 27, 2023 | 206.38B |
| September 26, 2023 | 209.16B |
| September 25, 2023 | 212.32B |
| September 22, 2023 | 213.78B |
| September 21, 2023 | 207.61B |
| September 20, 2023 | 211.31B |
| September 19, 2023 | 202.53B |
| September 18, 2023 | 203.74B |
| September 15, 2023 | 214.32B |
| September 14, 2023 | 206.14B |
| September 13, 2023 | 201.61B |
| September 12, 2023 | 204.94B |
| September 11, 2023 | 210.32B |
| September 08, 2023 | 210.32B |
| September 07, 2023 | 208.74B |
| September 06, 2023 | 207.53B |
| September 05, 2023 | 207.53B |
| September 01, 2023 | 210.79B |
| August 31, 2023 | 207.75B |
| August 30, 2023 | 211.91B |
| August 29, 2023 | 215.59B |
| August 28, 2023 | 211.78B |
| August 25, 2023 | 210.74B |
| Date | Value |
|---|---|
| August 24, 2023 | 210.78B |
| August 23, 2023 | 215.98B |
| August 22, 2023 | 210.47B |
| August 21, 2023 | 212.26B |
| August 18, 2023 | 210.83B |
| August 17, 2023 | 213.07B |
| August 16, 2023 | 213.20B |
| August 15, 2023 | 213.20B |
| August 14, 2023 | 221.94B |
| August 11, 2023 | 219.34B |
| August 10, 2023 | 213.81B |
| August 09, 2023 | 219.08B |
| August 08, 2023 | 219.08B |
| August 07, 2023 | 218.97B |
| August 04, 2023 | 217.36B |
| August 03, 2023 | 215.45B |
| August 02, 2023 | 215.63B |
| August 01, 2023 | 221.40B |
| July 31, 2023 | 224.45B |
| July 28, 2023 | 218.28B |
| July 27, 2023 | 217.68B |
| July 26, 2023 | 217.76B |
| July 25, 2023 | 212.49B |
| July 24, 2023 | 215.87B |
| July 21, 2023 | 212.21B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
87.93B
Minimum
Jan 28 2019
237.28B
Maximum
Apr 24 2023
156.52B
Average
146.35B
Median
Market Cap Benchmarks
| GSK PLC | 74.22B |
| Adaptimmune Therapeutics PLC | 176.82M |
| Akari Therapeutics PLC | 19.97M |
| Biodexa Pharmaceuticals Plc | 1.181M |
Market Cap Related Metrics
| PE Ratio | 34.10 |
| PS Ratio | 4.735 |
| Price to Book Value | 5.598 |
| Price to Free Cash Flow | 32.11 |
| Price | 135.05 |
| Earnings Yield | 2.93% |
| Operating PE Ratio | 32.40 |
| Normalized PE Ratio | 37.51 |